UNSPSC 51284148: Ceftizoxime alapivoxil

This classification denotes a cephalosporin antibiotic with the molecular formula C22H28N6O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3MM3320LJN, chemically known as ( )-(pivaloyloxy)methyl (6r,7r)-7-(2-(2-(l-alanylamino)thiazol-4-yl)glyoxylamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate 7,2-(z)-(o)-methyloxime). but more generally known as ceftizoxime alapivoxil, which bears US NIH Compound Identifier 9578661.

UNSPSC 51284148 Ceftizoxime alapivoxil is a Commodity code that shows minimal alignment between its nominal scope—a specific pharmaceutical compound—and the actual state and local procurement activity recently solicited under this code. The opportunities posted against the code span emergency-response medical supplies, pharmacy benefit programs, and generic pharmaceutical procurement across multiple issuing bodies, but none explicitly reference ceftizoxime alapivoxil or other branded antibiotic preparations. The City of Tampa Fire Department Rescue Division issued an IFB for 169 line items of medical and first aid supplies including respiratory equipment, cardiac monitoring devices, and emergency consumables with an estimated contract value of $700,000.00. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP for generic multi-source pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with proposals due March 26, 2026. The Texas Health and Human Services Commission posted an RFI regarding a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program to gather vendor capabilities for direct contracting with manufacturers outside traditional pharmacy benefit manager channels. Seminole County, Florida solicited 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through IFB 60459723LAS with a due date of July 26, 2023.

The geographic spread encompasses Florida, Texas, and Minnesota as primary recent activity centers, with Oregon participating in MMCAP's cooperative purchasing vehicle. Issuing bodies include city fire departments, state health agencies, county public health departments, and multistate cooperative alliances. The code shows little relevant recent activity for a firm positioning itself to pursue state and local pharmaceutical procurement—the opportunities tagged under this code are dispersed across emergency medical supplies, generic pharmaceuticals for institutional distribution, and direct-to-manufacturer pharmacy initiatives that do not correspond to branded or specialty antibiotic sourcing. A business development professional should verify whether this code is correctly assigned to their target pharmaceutical product lines, as the mismatch between the code's nominal scope and current solicitation activity suggests miscoding or a dormant category within state and local procurement.